Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
2022 · European Journal of Endocrinology · 103 citations
https://doi.org/10.1530/eje-21-1186
W
Wassim Chemaitilly
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
8.6K
Citations
45
h-index
96
i10-index
Wassim Chemaitilly is an academic researcher. The author has contributed to research in topics: Childhood Cancer Survivors' Quality of Life & Acute Lymphoblastic Leukemia research & Neuroblastoma Research and Treatments. The author has an h-index of 45, co-authored 179 publications.
ORCID: 0000-0003-0717-5076Papers by this author
worksEffect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†
2017 · Human Reproduction · 39 citations
https://doi.org/10.1093/humrep/dex082
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
2021 · Pituitary · 36 citations
https://doi.org/10.1007/s11102-021-01173-0
Impact of ovarian transposition before pelvic irradiation on ovarian function among long‐term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study
2018 · Pediatric Blood & Cancer · 31 citations
https://doi.org/10.1002/pbc.27232
Selecting short-statured children needing growth hormone testing: Derivation and validation of a clinical decision rule
2008 · BMC Pediatrics · 14 citations
https://doi.org/10.1186/1471-2431-8-29
Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death
2015 · Scientific Reports · 9 citations
https://doi.org/10.1038/srep16488
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat